Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy

Research output: Contribution to journalReview articlepeer-review

Abstract

In the era of precision medicine, liquid biopsy is becoming increasingly important in oncology. It consists in the isolation and analysis of tumor-derived biomarkers, including extracellular vesicles (EVs), in body fluids. EVs are lipid bilayer-enclosed particles, heterogeneous in size and molecular composition, released from both normal and neoplastic cells. In tumor context, EVs are valuable carriers of cancer information; in fact, their amount, phenotype and molecular cargo, including proteins, lipids, metabolites and nucleic acids, mirror nature and origin of parental cells rendering EVs appealing candidates as novel biomarkers. Translation of these new potential diagnostic tools into clinical practice could deeply revolutionize the cancer field mainly for solid tumors but for hematological neoplasms, too.

Original languageEnglish
JournalLeukemia
DOIs
Publication statusAccepted/In press - 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy'. Together they form a unique fingerprint.

Cite this